Riskpilot← Back to searchSign inGet full accessJolvin AB
ABActiveOrg 5563078285Slottstorget 5 B 2trGeneral medical practice activities · NACE 8621Est. 19870 employees
Revenue 2024
SEK 0
EBITDA margin
—
-77% vs 2023
Equity ratio
99.8%
Financial strength
Net profit 2024
SEK 156K
-85% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -154K | -77% |
| Net profit | SEK 156K | -85% |
| Total assets | SEK 16,1M | +0% |
| Equity | SEK 16M | +0% |
| Employees | 0 | — |
Legal name
Jolvin AB
Org number
5563078285
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
15 oktober 1987
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva sjuk- och friskvård samt äga och förvalta fast egendom och värdepapper ävensom idka därmed förenlig verksamhet.
Address
Slottstorget 5 B 2tr
Phone
+46706338498
Email
hakan.kihlstrom@telia.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 985 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | −8 | −0 | — |
| EBITDA | 161 | −156 | −95 | −87 | −154 |
| Depreciation & amort. | −72 | −0 | — | — | — |
| EBIT | 89 | −156 | −95 | −87 | −154 |
| Net financials | 16 769 | — | −1 118 | 1 119 | 310 |
| Profit before tax | 17 075 | −156 | −1 213 | 1 031 | 156 |
| Tax | −0 | −0 | — | — | — |
| Net profit | 17 075 | −156 | −1 213 | 1 031 | 156 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 17 393 | 16 779 | 15 249 | 16 102 | 16 056 |
| Equity | 17 203 | 16 636 | 15 236 | 16 073 | 16 024 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 190 | 143 | 13 | 29 | 33 |
| Total debt | 190 | 143 | 13 | 29 | 33 |
EBITDA margin
-15424900.0%
This company
15.8%
Market median
-97626049% vs market
20202024
Equity ratio
99.8%
This company
38.2%
Market median
+161% vs market
20202024
Return on equity
1.0%
This company
18.4%
Market median
-95% vs market
20202024
Net profit margin
15601900.0%
This company
8.1%
Market median
+192615949% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
LA Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Jolvin AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Anders Håkan Kihlström | Chief Executive Officer | 0 companies |
| Ylva Birgitta Kihlström | Deputy Board Member | 0 companies |